RecruitingPhase 2NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Sponsor: Oncolytics Biotech
Florham Park, NJ · New Brunswick, NJ · +15 more sites